INTERNATIONAL PATENT: H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. FILES APPLICATION FOR "CDK12 INHIBITORS WITH IMIDAZOLE[1,2-A] PYRAZINES"

GENEVA, Nov. 5 -- H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. (12902 Magnolia DriveTampa, Florida 33612) filed a patent application (PCT/US2025/026021) for "CDK12 INHIBITORS WITH IMIDAZOLE[1,2-A] PYRAZINES" on Apr 23, 2025. With publication no. WO/2025/226846, the details related to the patent application was published on Oct 30, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MONASTYRSKYI, Andrii (12902 Magnolia DriveTampa, Florida 33612), DUCKETT, Derek (12902 Magnolia DriveTampa, Florida 33612)

Abstract: Disclosed are substituted purine derivatives of formulae (I), and phar...